Episodes

  • Opus Genetics Reports Promising Early Results from BEST1 Gene Therapy Trial

    Opus Genetics Reports Promising Early Results from BEST1 Gene Therapy Trial
    Mar 2 2026
    First patient shows vision improvements with a good safety profile.
    Show More Show Less
    3 mins
  • Eye on the Cure Podcast | Episode 100: BEST OF

    Eye on the Cure Podcast | Episode 100: BEST OF
    Feb 27 2026
    To celebrate episode 100 of Eye on the Cure, host Ben Shaberman features highlights from conversations with some of his previous guests including: Dr. Dean Bok from UCLA, Dr. Michel Michaelides from Moorfields Eye Hospital, actor Ben Mehl, triathlete Michael Stone, and jazz keyboardist Matthew Whitaker. This "Best Of" episode is Ben's final for Eye on the Cure, but the podcast will continue on with a new host. Stay tuned!
    Show More Show Less
    36 mins
  • SparingVision Completes Dosing in Gene-Agnostic Therapy Trial for Retinitis Pigmentosa (RP)

    SparingVision Completes Dosing in Gene-Agnostic Therapy Trial for Retinitis Pigmentosa (RP)
    Feb 11 2026
    Novel neuroprotective approach could benefit RP patients regardless of genetic mutation
    Show More Show Less
    3 mins
  • Blind & Beyond Radio Spotlight: Jason Menzo on Vision Research and Advocacy

    Blind & Beyond Radio Spotlight: Jason Menzo on Vision Research and Advocacy
    Feb 8 2026
    Listen to the latest episode of the Blind & Beyond radio show featuring Foundation Fighting Blindness CEO Jason Menzo. Jason discusses the Foundation's mission and the remarkable progress achieved over the past 55 years in advancing diagnostics, treatments, and cures for blinding diseases. He also shares insights into ongoing advocacy efforts on Capitol Hill to preserve critical vision research funding through the FDA and National Eye Institute. The conversation concludes with an invitation for listeners to register for VISIONS 2026, the Foundation's global conference taking place June 12–13 in Fort Worth, Texas.
    Show More Show Less
    15 mins
  • Eye on the Cure Podcast | Episode 99: Dr. Prem Subramanian

    Eye on the Cure Podcast | Episode 99: Dr. Prem Subramanian
    Feb 6 2026
    Dr. Prem Subramanian, of the University of Colorado Sue Anschutz-Rodgers Eye Center and School of Medicine, talks with host Ben Shaberman about thyroid eye disease (TED), a condition that is often misdiagnosed and can cause a range of symptoms including discomfort and vision loss. Dr. Subramanian discusses potential causes, symptoms, and therapeutic approaches. This episode is sponsored by Amgen.
    Show More Show Less
    28 mins
  • Opus Genetics Receives Funding for Gene Therapy Clinical Trial for MERTK-Related RP

    Opus Genetics Receives Funding for Gene Therapy Clinical Trial for MERTK-Related RP
    Jan 28 2026
    Marking an important milestone for this rare form of retinitis pigmentosa (RP)
    Show More Show Less
    2 mins
  • AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B

    AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B
    Jan 16 2026
    Milestone brings hope to patients with rare inherited retinal disease
    Show More Show Less
    2 mins
  • SpliceBio Begins Dose-Expansion Phase of Clinical Trial for Stargardt Disease Protein Splicing Therapy

    SpliceBio Begins Dose-Expansion Phase of Clinical Trial for Stargardt Disease Protein Splicing Therapy
    Jan 13 2026
    First patient treated in Part B of ASTRA trial evaluating SB-007.
    Show More Show Less
    3 mins